Why Allakos Stock Was Soaring

Order By

KEY POINTS After Allkos announced poor late-stage trial results last year, the biotech stock lost most...

Sep 1

by Stacy Brooks

KEY POINTS Gilead Sciences provided a piece of good news about a cancer treatment. It wasn’t...

Aug 16

by Stacy Brooks

KEY POINTS Gilead Sciences’ primary market, which focuses on HIV, is in good shape. The firm...

Aug 10

by Stacy Brooks

KEY POINTS Pfizer and BioNTech were given a larger initial order for omicron boosters by the...

Aug 4

by Stacy Brooks

KEY POINTS Japan and Australia gave their stamp of approval to the Novavax COVID-19 vaccine for...

Jul 27

by Stacy Brooks

KEY POINTS A new supply arrangement helps the firm complete a vital pipeline project. Clovis Laboratories...

Jul 21

by Stacy Brooks

What’s going on with Adaptimmune stock Shares of Adaptimmune Therapeutics were jumping yesterday. The British cell...

Jun 28

by Stacy Brooks